Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.20 $16.47 Friday, 10th May 2024 VRDN stock ended at $13.90. This is 0.0719% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.32% from a day low at $13.34 to a day high of $14.05.
90 days $12.20 $21.42
52 weeks $10.93 $28.35

Historical Viridian Therapeutics, Inc. prices

Date Open High Low Close Volume
Jun 20, 2023 $27.11 $27.24 $24.25 $25.04 1 295 408
Jun 16, 2023 $28.12 $28.35 $26.54 $27.12 1 832 524
Jun 15, 2023 $27.66 $28.10 $27.26 $27.87 439 172
Jun 14, 2023 $27.36 $27.98 $26.86 $27.67 877 582
Jun 13, 2023 $25.45 $26.67 $25.45 $26.54 790 048
Jun 12, 2023 $25.75 $26.55 $25.42 $25.50 485 032
Jun 09, 2023 $25.48 $25.96 $25.11 $25.52 409 566
Jun 08, 2023 $25.15 $25.50 $24.69 $25.47 366 744
Jun 07, 2023 $24.99 $25.28 $24.75 $25.16 342 462
Jun 06, 2023 $24.89 $25.16 $24.69 $24.99 554 910
Jun 05, 2023 $24.27 $25.09 $24.04 $24.87 548 239
Jun 02, 2023 $24.61 $24.84 $23.80 $24.38 443 992
Jun 01, 2023 $24.07 $24.97 $23.90 $24.50 726 990
May 31, 2023 $24.00 $24.49 $23.72 $23.83 707 664
May 30, 2023 $24.23 $24.62 $23.53 $23.99 374 149
May 26, 2023 $23.65 $23.96 $23.34 $23.73 265 070
May 25, 2023 $23.90 $24.02 $23.25 $23.81 415 659
May 24, 2023 $24.82 $25.03 $23.63 $23.97 674 666
May 23, 2023 $24.67 $25.16 $24.45 $24.88 764 065
May 22, 2023 $23.27 $24.85 $23.05 $24.76 1 236 295
May 19, 2023 $22.94 $23.37 $22.59 $23.09 464 620
May 18, 2023 $22.81 $23.00 $21.96 $22.57 463 744
May 17, 2023 $23.47 $23.47 $22.50 $22.91 429 249
May 16, 2023 $23.02 $23.61 $22.80 $23.42 1 055 284
May 15, 2023 $23.59 $24.42 $23.32 $23.43 1 047 486
Click to get the best stock tips daily for free!

About Viridian Therapeutics, Inc.

Viridian Therapeutics. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as ... VRDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT